Share it: Subscribe
DistilNFO M & A
LifeSciences M&A Advisory

Weekly Top 10 News
Mon, 05 Nov 2018
M&A Perspectives
1. The Body Series: Disrupting Eye Healthcare
2. Trump outlines new plan to lower Medicare drug prices, end ‘rigged’ system
3. New technologies are accelerating drug development, bringing hope to patients
4. California’s New Health Mergers and Acquisition Laws
New M & A Activity
5. Lilly snaps up regulatory ‘fast pass’ for bargain price
6. Illumina to Acquire Pacific Biosciences for Approximately $1.2 Billion
7. Aya Healthcare Acquires Qualivis
8. Sanofi and Denali Therapeutics to develop treatments for neurological and inflammatory diseases
9. Akoya Biosciences Acquires Phenoptics Portfolio from PerkinElmer
10. Ophthotech Expands Innovative Retinal Disease Pipeline with Acquisition of Versant Ventures’ Inception 4
11. RTI Surgical® to Acquire Paradigm Spine
12. Precision BioLogic Acquires Affinity Biologicals
13. Mirion Technologies Dosimetry Services Division Acquires NRG’s Dosimetry Business in the Netherlands
14. OvaScience and Millendo Therapeutics Provide latest happenings on Merger Agreement and Financing
15. Aurora Cannabis Receives Lenders’ Consent for Proposed Acquisition of ICC
16. Grunenthal Agrees US$ 922 m Deal With AstraZeneca for Nexium and Vimovo
17. Alexion Completes Acquisition of Syntimmune
18. Conduent to Acquire Health Solutions Plus, Enhancing Core Administration Processing Capabilities
19. LifePoint Health Stockholders Approve Merger with RCCH HealthCare Partners
20. Riverchase Dermatology and Cosmetic Surgery Acquires Practice from Elba I. Rubianes, MD
21. Australis Finalizes Definitive Agreement to Acquire Rthm Technologies Inc.
22. Akebia Therapeutics Files Definitive Proxy Statement in Connection with Proposed Merger with Keryx Biopharmaceuticals
23. CRESCO LABS Expands Its Illinois Footprint With Prospective Acquisition Of Chicago-Area Dispensary
24. Covalon Announces Successful Completion of Operational Integration of AquaGuard Acquisition amid Continued Business Progress
25. Laboratoires Expanscience Acquires Babo Botanicals
26. GTCR and Cedar Gate Technologies Announce Acquisition of Global Healthcare Alliance
27. Thermo Fisher Scientific Completes Acquisition of Advanced Bioprocessing from BD
28. Generex Biotechnology Finalizes Acquisition of Remaining Veneto Operating Assets
29. GTCR and Resonetics acquire Medelec and STI
30. Sterling Bay Completes Purchase of Lurie Children’s Stanley Manne Children’s Research Institute
31. PA Consulting enhances global innovation and product design capability through acquisition of Essential Design
Other Corporate Development News
32. Takeda’s $80 Billion Acquisition of Shire Hits Snag in Europe
33. M&A, debt dampen US healthcare risk profile, report finds
34. Days after Alexion deal, Dicerna pens $100M upfront RNAi research pact with Eli Lilly
35. Novartis shares rise as it enters liver disease drug development deal with Pfizer
36. The Race To Find A Treatment For NASH
37. Orion Health Finalizes Investment Deal with Hg
About Ed Francis
DistilNFO's Executive Editor & Senior Industry Strategist.
Ed is the National Life Sciences Practice lead for West Monroe Partners & has more than 25 years of management consulting experience guiding some of the industry’s most prominent organizations.

If you need help with your complex transformation whether it be M&A, digital, strategic cost takeout Ed can be contacted at efrancis@wmp.com and +1-847-910-6073

Or connect with him at

Advertise with us

We Reach Quarter Million Decision Makers in:
Healthcare · IT · Retail · Industrial
Advertise with us and reach the right audience.
advertise@distilnfo.com

Contact Us


5760 Legacy Dr,
ste B3-405,
Plano TX 75024
+1 469-270-3311

About DistilNFO Newsletter

We pick up top 10 news from industries relevent to you and send out the headlines weekly thus saving your time and keeping you up to date on your interest areas.

SUBSCRIBE TO NEWSLETTER
OUR WEBSITE

You are receiving this newsletter because you are subscribed to one or more DistilNFO Publications Newsletter/s. If you feel this email was sent by mistake, you can unsubscribe or update your subscription.

View in browser | Update Subscription | Advertise | Contact Us